Arachidonic Acid Market Size & Growth Forecast 2027–2036, By Segments (Source, Application, Form), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Arachidonic Acid Market size was assessed at USD 242.79 Million in 2026 and is poised to grow at 4.64% CAGR between 2027 and 2036, exceeding USD 382.13 Million by 2036. The industry revenue for 2027 is estimated at USD 252.19 Million.

• Base Year Value (2026): USD 242.79 Million
• CAGR (2027-2036): 4.64%
• Forecast Year Value (2036): USD 382.13 Million
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Arachidonic Acid Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held 36.61% in 2026, supported by established nutritional and healthcare industries, specialized lipid demand, advanced research, and developed manufacturing infrastructure.
  • Asia Pacific is expected to grow fastest as infant nutrition demand, healthcare awareness, household incomes, and food and pharmaceutical manufacturing capabilities expand.

• Segment Momentum:

  • Infant formula led the market with a 46.96% share in 2026, as arachidonic acid remains an essential ingredient for supporting early growth and development in premium infant nutrition products.
  • The supplement segment is growing rapidly due to rising demand for functional nutrition, preventive healthcare, and personalized wellness products, supported by ongoing product innovation and increasing consumer interest in specialized nutrition.

• Market Expansion Drivers:

  • Rising demand for infant nutrition products driving arachidonic acid supplementation
  • Expanding pharmaceutical applications in anti-inflammatory and therapeutic formulations boosting usage
  • Growth in functional food and dietary supplements increasing bioactive ingredient adoption

• Leading Market Participants:

  Key players in the arachidonic acid market include DSM-Firmenich AG (Switzerland), BASF SE (Germany), Croda International Plc (United Kingdom), Cargill, Incorporated (United States), Lipoid GmbH (Germany), Cayman Chemical Company (United States), Zhejiang Medicine Co., Ltd. (China), Xiamen Kingdomway Group Company (China), Beijing Gingko Group (China), Kerry Group plc (Ireland)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 242.79 Million
  • 2027 Estimated Market Size: USD 252.19 Million
  • Projected Market Size: USD 382.13 Million by 2036
  • Growth Forecasts: 4.64% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Plant (Source) | Infant Formula (Application) | Solid (Form)
  • Emerging Opportunity Segment: Plant (Source) | Supplement (Application) | Solid (Form)

Market Growth Drivers and Industry Trends

Rising demand for infant nutrition products driving arachidonic acid supplementation

Increasing awareness of the nutritional requirements that support early childhood development is creating stronger demand for fortified infant nutrition products, which will drive the arachidonic acid market growth. Manufacturers are incorporating arachidonic acid into infant formula formulations to more closely align with nutritional profiles required during critical stages of growth and development. Rising preference for scientifically formulated nutrition products is encouraging broader adoption of specialized ingredients that support comprehensive infant dietary needs.

Expanding pharmaceutical applications in anti-inflammatory and therapeutic formulations boosting usage

Ongoing research into bioactive lipids is broadening their role in therapeutic development, and the arachidonic acid market is gaining momentum through expanding pharmaceutical applications. Arachidonic acid serves as an important biochemical component in physiological pathways that are relevant to inflammation, immune responses, and cellular signaling, supporting its use in research and specialized therapeutic formulations. Pharmaceutical innovation continues to explore its potential across targeted treatment approaches that require carefully characterized functional ingredients.

Growth in functional food and dietary supplements increasing bioactive ingredient adoption

Consumer preference for health-oriented nutrition products will propel the arachidonic acid market growth as manufacturers expand their portfolios of functional foods and dietary supplements containing bioactive ingredients. Demand is increasing for products that support overall wellness, active lifestyles, and personalized nutrition, encouraging the inclusion of specialized compounds with recognized physiological roles. Product developers are also introducing differentiated formulations that combine multiple functional ingredients to address evolving consumer expectations for convenient nutritional solutions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising demand for infant nutrition products driving arachidonic acid supplementation	2%	High	Asia Pacific, North America	High	Near Term
Expanding pharmaceutical applications in anti-inflammatory and therapeutic formulations boosting usage	1.6%	High	Europe, North America	Medium	Mid Term
Growth in functional food and dietary supplements increasing bioactive ingredient adoption	1.4%	Moderate	Asia Pacific, Europe	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the arachidonic acid market, North America held the largest share of 36.61% in 2026, supported by established nutritional and healthcare industries and strong demand for specialized lipid ingredients. The region benefits from growing awareness of the role of essential fatty acids in infant nutrition, dietary formulations, and health-focused products. Well-developed food and pharmaceutical manufacturing infrastructure, advanced research capabilities, and established distribution networks further support the adoption of arachidonic acid across diverse end-use applications.

Asia Pacific is expected to register the fastest growth, driven by expanding infant nutrition demand, rising healthcare awareness, and the development of food and pharmaceutical manufacturing capabilities. Increasing urbanization and improving household incomes are encouraging greater consumption of fortified and nutrition-oriented products, while investments in healthcare infrastructure are strengthening demand for specialized nutritional ingredients. Growing attention to infant health and developmental nutrition across emerging economies is also creating favorable conditions for broader utilization of arachidonic acid in the region.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Source Segment Analysis: Plant (Largest & Fastest-Growing Segment)

The plant source segment dominated the arachidonic acid market, accounting for 62.02% of the market share in 2026, while also emerging as the fastest-growing source category. Growing preference for plant-derived ingredients, supported by advancements in biotechnology and sustainable production methods, has significantly strengthened demand for plant-based arachidonic acid. Manufacturers increasingly favor plant sources because they offer scalable production, consistent quality, and alignment with evolving consumer preferences for naturally sourced ingredients. These advantages continue to reinforce the segment's leadership and long-term growth potential.

Application Segment Analysis: Infant Formula (Largest Segment) vs Supplement (Fastest-Growing Segment)

The infant formula application segment accounted for 46.96% of the market share in 2026, making it the leading application area. Arachidonic acid plays an important role in infant nutrition by supporting early growth and development, making it a key ingredient in premium infant formula products. Continued emphasis on nutritional quality and scientifically formulated infant nutrition products has sustained strong demand within this application.

The supplement application segment is experiencing the fastest growth as consumers increasingly adopt nutritional products that support overall health and wellness. Rising awareness regarding functional ingredients, preventive healthcare, and personalized nutrition is encouraging broader incorporation of arachidonic acid into dietary supplements. Expanding product innovation and growing consumer interest in specialized nutrition continue to strengthen this segment across the arachidonic acid market.

Form Segment Analysis: Solid (Largest & Fastest-Growing Segment)

Holding the leading position in the arachidonic acid market, the solid form segment was the largest in 2026 while also recording the fastest growth. Solid formulations are widely preferred because they offer greater stability during storage, simplified handling, and compatibility with a broad range of manufacturing processes used across food, nutritional, and pharmaceutical applications. Their ease of transportation and formulation flexibility further support extensive commercial adoption. Ongoing product development and expanding demand for stable ingredient formats continue to reinforce the segment's market leadership.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Source	Plant, Animal	Plant	Plant
Application	Infant Formula, Supplement, Others	Infant Formula	Supplement
Form	Solid, Solvent	Solid	Solid

Competitive Landscape and Market Positioning

Key companies in the arachidonic acid market:

1. DSM-Firmenich AG (Switzerland)
2. BASF SE (Germany)
3. Croda International Plc (United Kingdom)
4. Cargill Incorporated (United States)
5. Lipoid GmbH (Germany)
6. Cayman Chemical Company (United States)
7. Zhejiang Medicine Co., Ltd. (China)
8. Xiamen Kingdomway Group Company (China)
9. Beijing Gingko Group (China)
10. Kerry Group plc (Ireland)

Advances in ingredient manufacturing and quality assurance are redefining competition in the arachidonic acid market as suppliers focus on delivering highly consistent formulations suitable for nutrition, pharmaceutical, and research applications. The competitive emphasis is gradually moving toward production technologies that improve purity, traceability, and process efficiency while meeting increasingly stringent quality expectations across regulated end-use sectors. Manufacturers are also differentiating through application-specific formulation capabilities, enabling customers to integrate arachidonic acid into diverse product categories with greater stability and compatibility. As purchasing decisions become more closely tied to supply reliability and technical documentation, companies with robust manufacturing controls and specialized formulation expertise are gaining a stronger competitive position.

Industry Development/News

Company Name	Date	Key Development
Danone	May-26	Danone faced intensified regulatory oversight and scrutiny regarding the execution speed of its product recall protocols for infant formula products potentially affected by ingredient contamination. The situation underscores heightening quality assurance and risk management expectations across the global infant nutrition value chain.
dsm-firmenich	Feb-26	dsm-firmenich introduced comprehensive guidelines for infant formula manufacturers to enhance arachidonic acid ingredient sourcing security. The strategy focuses on verifying supplier manufacturing processes and assessing alternative arachidonic acid formulations to stabilize the supply chain amid widespread international ingredient recalls.
Nestlé	Jan-26	Nestlé expanded its product recall of selected infant formula lines containing contaminated arachidonic acid oil to regions across Africa, the Americas, and Asia. The widespread geographic expansion of the recall represents a significant operational response to mitigate supply chain contamination risks across international consumer markets.
HiPP	Jan-26	HiPP leveraged its European-centric supply chain and rigorous multi-layer quality management system to successfully prevent contamination and isolate its inventory from global infant formula recalls. The operational insulation highlights the competitive advantage of localized ingredient sourcing and robust preventive quality frameworks.